Scientists from the University of Birmingham (UK) are in the process of developing a new blood test that could facilitate earlier and more accurate prostate cancer detection.
Browsing: clinical diagnostics
Scientists from Prokhorov General Physics Institute of the Russian Academy of Sciences (Moscow, Russia) and the Moscow Institute of Physics and Technology (Russia) have developed a new tool to that could improve the diagnosis and monitoring of autoimmune disorders.
Thermo Fisher Scientific (MA, USA), WuXi Diagnostics (Shanghai, China) and Mayo Clinic (MN, USA) are collaborating to develop and validate a serology test for COVID-19.
Emergency use authorization for Thermo Fisher Scientific’s COVID-19 diagnostic test expanded by US FDA
The US FDA has expanded the emergency use authorization granted to Thermo Fisher Scientific’s (MA, USA) COVID-19 diagnostic test. The expansion could facilitate workflow flexibility and increase test throughput.
Mologic (Bedford, UK) and BioSure (Essex, UK) have entered a partnership to produce an antibody self-test for COVID-19 that does not require specialist equipment or training to carry out.
A study led by researchers from Brussels Academic Hospital Lab (LHUB-ULB, Brussels, Belgium) indicates that the COVID-19 Ag Respi-Strip® – an antigen test for COVID-19 – could be a useful component in broader testing strategies.
Researchers from Icahn School of Medicine at Mount Sinai (NY, USA) have developed a step-by-step protocol for a serological test that can detect antibodies to SARS-CoV-2.
Genedrive (Manchester, UK) and Cytiva (formerly GE Healthcare; IL, USA) have entered an international collaboration to develop a one step assay to detect SARS-CoV-2 for use on lab-based PCR instruments.
Researchers from institutions across Korea have developed a rapid antibody test to detect SARS-CoV-2 based on a field-effect transistor. The test can distinguish healthy individuals’ nasopharyngeal swab samples from COVID-19 patients’ swabs with no sample preparation required.
Scientists from The University of Zurich (Switzerland) and Institute of Environmental Engineering (Zurich, Switzerland) have developed a diagnostic assay to detect RNA sequences from SARS-CoV-2, the virus responsible for COVID-19.